Potentiality and Boundaries of Use of Sorafenib in Patients with Hepatocellular Carcinoma: Awaiting the Results of Ongoing Clinical Trials

Por Bruno Daniele, Francesco Perrone, Giuseppe Signoriello, Maria Carmela Piccirillo, Pasqualina Giordano, Gennaro Daniele, Massimo Di Maio
Publicado em 2012-06-01